577b8e15f4bb5c58573ae849_logo.png
AAA Logo transparent (2).png
1200px-King's_College_London_logo.svg.pn
logo_ark.jpg

MAJOR TOPICS OF SUMMIT WILL INCLUDE

Frontier applications of Artificial Intelligence in ageing research, longevity R&D and the development of biomarkers of health and longevity

The paradigm shift from disease treatment and sick care to preventive medicine, and from preventive medicine to precision health, utilizing nearly real-time assessment of biomarkers of ageing to coordinate micro-dose interventions to continually rebalance biomarkers of health and longevity and maintain an optimal state of precision health, and how AI will be necessary for the coordination of biomarker monitoring and interventions due to the sheer volume of data

The increasing shift toward actionable biomarkers of ageing, including the identification of biomarkers of health, longevity and aging that have the highest ratios of accuracy and precision vs. actionability, expense and ease-of-implementation, and the benchmarking of biomarkers that can be used in practice today

Emerging trends and novel paradigms relating to both the creation and application of life data, including the construction of biomarkers of ageing, longevity and health collected on a massive scale from healthy individuals and used in scientifically-backed, quantifiable, tangible and precise ways to preserve and maintain an optimal state of health

The creation of novel forms of biomarkers that are still in the initial R&D phase, including image-recognition and photographic biomarkers of ageing, vocal-recognition based biomarkers of aging, as well as gait, movement and accelerometer-based biomarkers of ageing

What biomarkers of health and longevity can be used today to assess individual’s personal state of health and track the effectiveness of behavioural, lifestyle and therapeutic interventions, as well as how and where to gain access to the leading longevity diagnostic and prognostic technologies that are just now reaching the threshold of real-world practical application

An overview of how biomarkers of health, longevity and aging can be used at scale by governments to track, measure and test the efficacy of programs and development plans aiming to increase National Healthy Longevity

Contact Us